×
About 1,527 results

ALLMedicine™ Bone Biopsy Center

Research & Reviews  755 results

The Role of Bone Biopsy in the Management of CKD-MBD.
https://doi.org/10.1007/s00223-021-00838-z 10.1038/sj.ki.5000414 10.1016/S2213-8587(14)70059-2 10.1016/j.kint.2017.04.006 10.1016/j.fertnstert.2019.10.005 10.1111/nep.12570 10.1016/j.bone.2017.01.023 10.1007/s40620-017-0404-z 10.1016/j.kisu.2017.04.001 10.2215/CJN.12871211 10.1093/ndt/gfr317 10.1111/j.1600-6143.2008.02423.x 10.1111/sdi.12423 10.1007/s00198-011-1568-3 10.1159/000510064 10.1097/01.mnh.0000447014.36475.58 10.1016/j.semnephrol.2014.09.004 10.1007/s11914-013-0142-7 10.1002/jmri.20807 10.1007/s00198-012-1908-y 10.1002/jbmr.2176 10.1007/s00198-018-4468-y 10.1053/j.ajkd.2015.06.020 10.1046/j.1523-1755.2000.00178.x 10.1016/j.kint.2018.12.024 10.1038/sj.ki.5001754 10.1038/nrneph.2009.192 10.4330/wjc.v6.i4.115 10.1007/s00223-013-9790-y 10.1053/j.ajkd.2015.06.023 10.21037/qims.2018.01.02 10.1093/ndt/15.suppl_5.8 10.4081/ejh.2011.e1 10.1007/s00467-020-04499-2 10.1016/j.kint.2017.07.021 10.2215/CJN.11031017 10.1046/j.1523-1755.63.s85.13.x 10.1056/NEJM198502213120803 10.1038/ki.1987.75 10.1002/jbmr.4235 10.1002/jbmr.3961 10.1177/089686080102103S45 10.1210/clinem/dgaa851 10.1210/jc.2014-1154 10.1002/jbmr.3676 10.1007/s00198-019-05038-y 10.1159/000316708 10.1056/NEJMoa1305224 10.1002/jbmr.3735 10.1002/jbmr.173 10.1056/NEJMoa1708322 10.1210/jc.2017-02163 10.1186/1471-2369-15-190 10.1038/ki.2015.194 10.1093/ndt/gfu301 10.1093/ndt/gft039 10.1038/ki.1981.149 10.1146/annurev.me.37.020186.000455 10.1093/ndt/17.suppl_2.21 10.1038/ki.1986.246 10.1016/S0272-6386(85)80089-5 10.1093/ndt/15.9.1328 10.1038/ki.1989.136 10.1097/01.mnh.0000133973.86816.e9 10.1177/0091270006289846 10.1097/01.ASN.0000133022.32912.95 10.1111/j.1523-1755.2005.00281.x 10.1046/j.1523-1755.63.s85.18.x 10.1093/ndt/gfq124 10.1016/S0272-6386(12)80497-5 10.1093/ndt/5.9.781 10.1093/ndt/13.suppl_3.46 10.3390/nu7042324 10.1093/ndtplus/sfr166 10.1111/j.1525-139X.2008.00530.x 10.1093/clinchem/45.9.1548 10.1155/2015/380247 10.1046/j.1523-1755.1999.00740.x 10.1046/j.1523-1755.2000.00938.x 10.1046/j.1523-1755.1998.00035.x 10.1046/j.1523-1755.2003.00809.x
Calcified Tissue International; Ferreira AC, Cohen-Solal M et. al.

Mar 27th, 2021 - A bone biopsy is still considered the gold standard for diagnosis of renal osteodystrophy. It allows to measure both static and dynamic parameters of bone remodeling and is the only method able to evaluate mineralization and allows analysis of bot...

GATA-3 expression in a de-differentiated chondrosarcoma with cutaneous iatrogenic impla...
https://doi.org/10.1111/cup.13995
Journal of Cutaneous Pathology; Henning A, Banks M et. al.

Mar 3rd, 2021 - De-differentiated chondrosarcoma (DDCS) is an extremely aggressive tumor of the bone characterized by a high-grade, non-chondroid sarcoma adjacent to a low- or intermediate-grade chondrosarcoma. Adequate tumor sampling demonstrating the biphasic f...

Late diagnosis of metastatic pheochromocytoma in multiple endocrine neoplasia 2B with r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868215
BMJ Case Reports; Jester G, Hassanein H et. al.

Feb 5th, 2021 - Multiple endocrine neoplasia type 2B (MEN2B) is the rarest and most aggressive of the MEN syndromes. It is characterised by medullary thyroid cancer (MTC), pheochromocytoma, marfanoid body habitus, mucosal neuromas and colonic dysfunction. Patient...

Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to to...
https://doi.org/10.1016/j.kint.2020.12.024
Kidney International; Ursem SR, Heijboer AC et. al.

Jan 10th, 2021 - Parathyroid hormone (PTH) is a key regulator of bone turnover but can be oxidized in vivo, which impairs biological activity. Variable PTH oxidation may account for the rather poor correlation of PTH with indices of bone turnover in chronic kidney...

see more →

Clinicaltrials.gov  765 results

The Role of Bone Biopsy in the Management of CKD-MBD.
https://doi.org/10.1007/s00223-021-00838-z 10.1038/sj.ki.5000414 10.1016/S2213-8587(14)70059-2 10.1016/j.kint.2017.04.006 10.1016/j.fertnstert.2019.10.005 10.1111/nep.12570 10.1016/j.bone.2017.01.023 10.1007/s40620-017-0404-z 10.1016/j.kisu.2017.04.001 10.2215/CJN.12871211 10.1093/ndt/gfr317 10.1111/j.1600-6143.2008.02423.x 10.1111/sdi.12423 10.1007/s00198-011-1568-3 10.1159/000510064 10.1097/01.mnh.0000447014.36475.58 10.1016/j.semnephrol.2014.09.004 10.1007/s11914-013-0142-7 10.1002/jmri.20807 10.1007/s00198-012-1908-y 10.1002/jbmr.2176 10.1007/s00198-018-4468-y 10.1053/j.ajkd.2015.06.020 10.1046/j.1523-1755.2000.00178.x 10.1016/j.kint.2018.12.024 10.1038/sj.ki.5001754 10.1038/nrneph.2009.192 10.4330/wjc.v6.i4.115 10.1007/s00223-013-9790-y 10.1053/j.ajkd.2015.06.023 10.21037/qims.2018.01.02 10.1093/ndt/15.suppl_5.8 10.4081/ejh.2011.e1 10.1007/s00467-020-04499-2 10.1016/j.kint.2017.07.021 10.2215/CJN.11031017 10.1046/j.1523-1755.63.s85.13.x 10.1056/NEJM198502213120803 10.1038/ki.1987.75 10.1002/jbmr.4235 10.1002/jbmr.3961 10.1177/089686080102103S45 10.1210/clinem/dgaa851 10.1210/jc.2014-1154 10.1002/jbmr.3676 10.1007/s00198-019-05038-y 10.1159/000316708 10.1056/NEJMoa1305224 10.1002/jbmr.3735 10.1002/jbmr.173 10.1056/NEJMoa1708322 10.1210/jc.2017-02163 10.1186/1471-2369-15-190 10.1038/ki.2015.194 10.1093/ndt/gfu301 10.1093/ndt/gft039 10.1038/ki.1981.149 10.1146/annurev.me.37.020186.000455 10.1093/ndt/17.suppl_2.21 10.1038/ki.1986.246 10.1016/S0272-6386(85)80089-5 10.1093/ndt/15.9.1328 10.1038/ki.1989.136 10.1097/01.mnh.0000133973.86816.e9 10.1177/0091270006289846 10.1097/01.ASN.0000133022.32912.95 10.1111/j.1523-1755.2005.00281.x 10.1046/j.1523-1755.63.s85.18.x 10.1093/ndt/gfq124 10.1016/S0272-6386(12)80497-5 10.1093/ndt/5.9.781 10.1093/ndt/13.suppl_3.46 10.3390/nu7042324 10.1093/ndtplus/sfr166 10.1111/j.1525-139X.2008.00530.x 10.1093/clinchem/45.9.1548 10.1155/2015/380247 10.1046/j.1523-1755.1999.00740.x 10.1046/j.1523-1755.2000.00938.x 10.1046/j.1523-1755.1998.00035.x 10.1046/j.1523-1755.2003.00809.x
Calcified Tissue International; Ferreira AC, Cohen-Solal M et. al.

Mar 27th, 2021 - A bone biopsy is still considered the gold standard for diagnosis of renal osteodystrophy. It allows to measure both static and dynamic parameters of bone remodeling and is the only method able to evaluate mineralization and allows analysis of bot...

GATA-3 expression in a de-differentiated chondrosarcoma with cutaneous iatrogenic impla...
https://doi.org/10.1111/cup.13995
Journal of Cutaneous Pathology; Henning A, Banks M et. al.

Mar 3rd, 2021 - De-differentiated chondrosarcoma (DDCS) is an extremely aggressive tumor of the bone characterized by a high-grade, non-chondroid sarcoma adjacent to a low- or intermediate-grade chondrosarcoma. Adequate tumor sampling demonstrating the biphasic f...

Late diagnosis of metastatic pheochromocytoma in multiple endocrine neoplasia 2B with r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868215
BMJ Case Reports; Jester G, Hassanein H et. al.

Feb 5th, 2021 - Multiple endocrine neoplasia type 2B (MEN2B) is the rarest and most aggressive of the MEN syndromes. It is characterised by medullary thyroid cancer (MTC), pheochromocytoma, marfanoid body habitus, mucosal neuromas and colonic dysfunction. Patient...

Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to to...
https://doi.org/10.1016/j.kint.2020.12.024
Kidney International; Ursem SR, Heijboer AC et. al.

Jan 10th, 2021 - Parathyroid hormone (PTH) is a key regulator of bone turnover but can be oxidized in vivo, which impairs biological activity. Variable PTH oxidation may account for the rather poor correlation of PTH with indices of bone turnover in chronic kidney...

see more →

News  5 results

Rivaroxaban beats aspirin for VTE
https://www.mdedge.com/neurology/article/173862/mixed-topics/rivaroxaban-beats-aspirin-vte

Aug 31st, 2018 - Both low-dose and full-dose rivaroxaban had superior benefit-risk profiles for extended VTE compared with aspirin. Also today, bone biopsy diagnostics for osteomyelitis vary widely, variation in bacterial drug susceptibility are tied to the risk o.

Bone biopsy in suspected osteomyelitis: Culture and histology matter
https://www.mdedge.com/familymedicine/article/173674/diabetes/bone-biopsy-suspected-osteomyelitis-culture-and-histology/page/0/2
Clinical Endocrinology News;

Aug 29th, 2018 - Pathology and culture are standard of care when evaluating for osteomyelitis and should be a covered service. However, a patient should call their insurance company first prior to having the procedure done to see whether it is covered.

A 68-Year-Old Man With Severe Joint Pain and Nodules
https://reference.medscape.com/viewarticle/886160_3

Sep 28th, 2017 - Discussion CT of the abdomen revealed a 1.8 cm × 1.4 cm hypodense lesion within the pancreatic head, with calcifications and mild proximal pancreatic ductal dilatation. Subsequent endoscopic ultrasonography revealed a 16 mm × 17 mm hypoechoic stru...

Less Invasive Method IDs Bone Infection in Diabetic Foot
https://www.medscape.com/viewarticle/781442

Mar 25th, 2013 - In a small study of diabetic patients presenting with a foot ulcer and no signs of soft-tissue infection, bone infection was safely and accurately diagnosed in a 2-step method that included less invasive bedside bone puncture rather than a bone bi...

Less Invasive Method IDs Bone Infection in Diabetic Foot
https://www.staging.medscape.com/viewarticle/781442

Mar 25th, 2013 - In a small study of diabetic patients presenting with a foot ulcer and no signs of soft-tissue infection, bone infection was safely and accurately diagnosed in a 2-step method that included less invasive bedside bone puncture rather than a bone bi...

see more →

Patient Education  2 results see all →